Based on the TCGA-BRCA level 3 data, Table 1 showed the clinical characteristics of tumor samples, such as molecular subtype, histological type, menopause status, radiation therapy, margin status, neoadjuvant treatment, targeted molecular therapy, ER, PR, HER-2, TNM stage, clinical stage, vital status, lymph node status and sample type. The gene discussed is PGR; the disease is neoplasm.